United States Advanced Cardiovascular Life Support (ACLS) Market Insight
Published: 25 May 2026 | Report Format: Electronic (PDF)
The Cardiovascular Life Support (ACLS) market size in the United States is continuously growing, with an average growth rate of 4.06%, which is largely fueled by factors such as increased cases of cardiovascular disorders, heightened awareness of emergency care, and growing use of advanced cardiac resuscitation equipment.
U.S. Advanced Cardiovascular Life Support (ACLS) Market Insights Forecasts to 2035
- The US Advanced Cardiovascular Life Support (ACLS) Market Size Was Estimated at USD 826.03 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 4.06% from 2025 to 2035
- The US Advanced Cardiovascular Life Support (ACLS) Market Size is Expected to Reach USD 1220 Million by 2035
Notable Insights for U.S. Advanced Cardiovascular Life Support (ACLS) Market
- In terms of equipment type, defibrillators dominated the United States ACLS market with nearly 34% share in 2025.
- Based on applications, cardiac arrest accounted for over 42% share of the total US ACLS market, owing to rising incidences of arrhythmia, coronary artery disease, strokes, and sudden cardiac arrest cases in the country.
- As part of healthcare emergency readiness, the United States dedicated more than USD 640 million in terms of funding towards cardiac emergency response systems, patient monitoring by telehealth, resuscitation training through simulation technology, and modernizing critical care services in the period from 2024 to 2026, enhancing the capacity for the implementation of ACLS.
Download the eBook (ToC)
- With respect to upgrading hospitals and improving their capacity for emergency response, the United States reportedly invested around USD 590 million in emergency medical technology, patient monitoring, and cardiovascular critical care technology utilizing AI technology.
Why Buy This Report
- Gain more comprehensive and strategic information on the market for advanced cardiovascular life support in the United States, which includes advancements in technology associated with emergency cardiac care, medical training simulations, AI-powered patient monitoring, and the trend towards modernization of resuscitation devices.
- Obtain a better understanding of the changes that the development of cardiovascular diseases, expansion of emergency response networks, use of telemedicine, and robotics is having on the ACLS environment in hospitals, ambulatory care facilities, and EMS across the country.
- Recognize investment prospects from the trend toward digitization of critical care, advancements in defibrillation techniques, portable cardiac monitors, and other AI-based emergency response innovations impacting the American field of cardiovascular emergencies.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the US Advanced Cardiovascular Life Support (ACLS) market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Advanced Cardiovascular Life Support (ACLS) Market
- Medtronic plc
- GE HealthCare
- Philips Healthcare
- ZOLL Medical Corporation
- Stryker Corporation
- Abbott Laboratories
- Boston Scientific Corporation
- Nihon Kohden Corporation
- Others
Recent Developments:
- In February 2026, the United States invested nearly USD 240 million toward emergency cardiac response modernization, ACLS simulation training systems, and AI-enabled cardiovascular monitoring technologies across hospitals and emergency medical service networks nationwide.
- In July 2025, leading ACLS equipment manufacturers increased investments by nearly USD 120 million toward advanced resuscitation technologies, portable monitoring devices, and automated external defibrillator innovation supporting emergency cardiovascular care modernization nationwide.
Market Segmentation:
United States Advanced Cardiovascular Life Support (ACLS) Market, By Equipment Type
- Defibrillators
- Cardiac Monitors
- Ventilators
- Cardiac Resuscitation Devices
- Others
United States Advanced Cardiovascular Life Support (ACLS) Market, By Application
- Cardiac Arrest Management
- Stroke Response
- Acute Coronary Syndrome
- Arrhythmia Monitoring
- Others
United States Advanced Cardiovascular Life Support (ACLS) Market, By End User
- Hospitals & Clinics
- Emergency Medical Services
- Ambulatory Surgical Centers
- Medical Training Centers
- Others
Expert Views:
The US long-term growth for advanced cardiovascular life support is projected due to the increasing importance of being well prepared for emergencies in healthcare organizations through effective infrastructures and innovative technologies for enhancing patient outcomes. In addition, innovations in areas such as artificial intelligence-based heart monitoring, transportable emergency care tools, telecritical care systems, and ACLS training simulators can be seen as playing a significant role in shaping the future of emergency cardiovascular care in the US healthcare industry. With hospitals becoming increasingly technologically sophisticated, it is likely that ACLS technologies will play an increasingly important role in emergency medical procedures.